4.3 Article

Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Randomized Controlled Trial

期刊

JOURNAL OF CLINICAL HYPERTENSION
卷 14, 期 5, 页码 322-329

出版社

WILEY
DOI: 10.1111/j.1751-7176.2012.00607.x

关键词

-

资金

  1. NIH/NCRR Colorado CTSI [KL2 RR025779]
  2. Novartis Pharmaceuticals Corporation

向作者/读者索取更多资源

Clinical inertia is a major contributor to poor blood pressure (BP) control. The authors tested the effectiveness of an intervention targeting physician, patient, and office system factors with regard to outcomes of clinical inertia and BP control. A total of 591 adult primary care patients with elevated BP (mean systolic BP =140 mm Hg or mean diastolic BP =90 mm Hg) were randomized to intervention or usual care. An outreach coordinator raised patient and provider awareness of unmet BP goals, arranged BP-focused primary care clinic visits, and furnished providers with treatment decision support. The intervention reduced clinical inertia (-29% vs -11%, P=.001). Nonetheless, change in BP did not differ between intervention and usual care (-10.1/-4.1 mm Hg vs -9.1/-4.5 mm Hg, P=.50 and 0.71 for systolic and diastolic BP, respectively). Future primary carefocused interventions might benefit from the use of specific medication titration protocols, treatment adherence support, and more sustained patient follow-up visits. J Clin Hypertens (Greenwich). 2012; 14:322329. (c) 2012 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据